Volume 13 Supplement 1
18th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Meeting abstracts
Edited by Peter Holzer and Thomas Griesbacher
18th Scientific Symposium of the Austrian Pharmacological Society (APHAR). Joint meeting with the Croatian, Serbian and Slovenian Pharmacological Societies. Go to conference site.
Graz, Austria20-21 September 2012
Page 1 of 2
-
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A1
-
Methadone-drugs interactions: possible causes of methadone-related deaths
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A2 -
Use of ACE inhibitors in Serbia in 2010
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A3 -
Differences in the use of medicines for peptic ulcer and gastro-esophageal reflux disease between Serbia, Croatia and Sweden
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A4 -
Remarkably lower consumption of antidepressants in Serbia in comparison with Finland
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A5 -
Considerable differences in the utilisation of antidiabetics between Serbia and Scandinavian countries
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A6 -
The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic syndrome
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A7 -
The GABAAreceptor α2 subunit gene (GABRA2) is associated with alcohol-related behavior
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A8 -
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A9 -
Drug Information Unit, Medical Faculty of Novi Sad
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A10 -
Influence of different Hypericum perforatumL. preparations on pharmacokinetic and pharmacodynamic properties of pentobarbital, diazepam and paracetamol
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A11 -
Acetaminophen changes paracellular transport activity through regulation of the tight junction protein in an intestinal barrier model
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A12 -
The role of CB2receptor ligands in human eosinophil function
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A13 -
Laropiprant attenuates EP3and TP prostanoid receptor-mediated thrombus formation
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A14 -
Uremia alters HDL composition and cholesterol efflux capacity
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A15 -
Alloxan-induced diabetes alters rat common carotid artery response to adenosine
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A16 -
A PET microdosing study with the P-glycoprotein inhibitor tariquidar
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A17 -
Role of perivascular adipose tissue in endothelial dysfunction of adipose triglyceride lipase-deficient mice
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A18 -
Characteristics of low affinity high capacity histamine uptake into neonatal rat astrocytes
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A19 -
The role of PGE2 EP4receptors in the regulation of endothelial barrier function
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A20 -
Bioactivation of nitroglycerin is determined by the subcellular localization of aldehyde dehydrogenase-2
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A21 -
Nitric oxide signaling in adipose triglyceride lipase-deficient microvascular endothelial cells
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A22 -
The atypical cannabinoid O-1602 shows antitumorigenic effects in colon cancer cells and reduces tumor growth in a colitis-associated colon cancer model
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A23 -
The relaxation of non-pregnant rat myometrium by resveratrol with participation of the NO–cGMP pathway
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A24 -
Improving the low solubility of resveratrol
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A25 -
Understanding subtype-selective allosteric modulation of GABAAreceptors
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A26 -
Herb-drug interactions: the influence of essential oil of caraway (Carum carviL.) on the pharmacokinetics of paracetamol
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A27 -
The role of nitric oxide and endothelin on optic nerve head blood flow autoregulation
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A28 -
The role of potassium channels in the mechanism of vasodilatation of human umbilical vein induced by resveratrol
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A29 -
The effect of chronic fluoxetine administration on anxiety-like behavior and expression of 5-HT-related proteins in rats with constitutively altered 5-HT homeostasis
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A30 -
Pharmacological applications of natural peptide libraries
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A31 -
Low affinity histamine uptake into neonatal rat astrocytes does not involve OCT
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A32 -
Influence of the 14-alkoxy group and the substitution in position 5 in N-methyl-14-alkoxymorphinan-6-ones on in vitro and in vivopharmacological activities
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A33 -
Plasma levels of an atropine/scopolamine mixture following ingestion of low doses as food contaminant
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A34 -
Potentially inappropriate medication use in the elderly in Montenegro
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A35 -
Tolerance to nitroglycerin through proteasomal degradation of aldehyde dehydrogenase-2 in a genetic mouse model of ascorbate deficiency
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A36 -
Vascular bioactivation of nitroglycerin: reaction mechanism revealed by crystal structure of aldehyde dehydrogenase-2
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A37 -
The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A38 -
Adverse drug reactions and polypharmacy in cardiac patients
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A39 -
Uremia-induced lysine modifications transform plasma albumin into a high-density lipoprotein receptor inhibitor
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A40 -
Impaired L-type Ca2+ channel function in the dystrophic heart
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A41 -
Histone deacetylase inhibitors, glutamatergic drugs and deep brain stimulation rescue resistance to fear extinction in a genetic mouse model
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A42 -
Discovery and biological evaluation of a diphenethylamine derivative (HS665), a highly potent and selective κ opioid receptor agonist
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A43 -
Neurobiological correlates of successful deep brain stimulation in a mouse model of high trait affect
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A44 -
Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A45 -
Functional implications of KV7 channel phosphorylation
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A46 -
Environmental enrichment and visceral inflammation regulate stress-induced c-Fos and NPY expression within the dentate gyrus
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A47 -
The differential effect of resveratrol on the renal artery of normal and diabetic rats
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A48 -
Regulation of CaV1.3 Ca2+channels in cochlear inner hair cells
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A49 -
A mouse model to study the C-terminal regulation of CaV1.3 L-type calcium channels
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A50
Annual Journal Metrics
-
2022 Citation Impact
2.9 - 2-year Impact Factor
2.9 - 5-year Impact Factor
0.932 - SNIP (Source Normalized Impact per Paper)
0.603 - SJR (SCImago Journal Rank)2022 Speed
22 days submission to first editorial decision for all manuscripts (Median)
198 days submission to accept (Median)2022 Usage
642,939 downloads
1,154 Altmetric mentions
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication